Page last updated: 2024-10-19

nitrates and Diabetes Mellitus, Adult-Onset

nitrates has been researched along with Diabetes Mellitus, Adult-Onset in 109 studies

Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.

Research Excerpts

ExcerptRelevanceReference
"Anemia is common in patients with type 2 diabetes."5.51Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats. ( Ghasemi, A; Jeddi, S; Khorasani, V; Tohidi, M; Yaghmaei, P, 2019)
" The effect of pioglitazone on composite endpoints was evaluated, including all-cause death, myocardial infarction (MI), and stroke, as well as safety events of edema and serious heart failure, in subgroups using nitrates, RAS blockers, or insulin at baseline."5.14Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20). ( Charbonnel, B; Erdmann, E; Spanheimer, R, 2010)
" Serum markers of inflammation (high-sensitivity C-reactive protein) and endothelial function (soluble intercell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, endothelin-1 and total nitrite) were assessed using nephelometry, immunoassays and spectroscopy."3.81Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy. ( Jenkins, AJ; Nguyen, TT; Sasongko, MB; Shaw, JE; Wang, JJ; Wong, TY, 2015)
"In this study we assessed the content of nitrites III and V in selected herbal medicaments used in obesity and diabetes mellitus type 2 treatment."3.73[Nitrite and nitrate content in selected herbal medicaments used in obesity and diabetes mellitus type 2 treatment]. ( Szydłowska, E; Szydłowski, W; Zareba, S, 2005)
" As low levels of nitric oxide (NO) may contribute to increased BP, we determined if increasing NO bioavailability via eight weeks of supplementation with beetroot juice containing inorganic nitrate/nitrite (4."3.11Dietary Inorganic Nitrate/Nitrite Supplementation Reduces Central and Peripheral Blood Pressure in Patients With Type 2 Diabetes Mellitus. ( Bock, JM; Casey, DP; Feider, AJ; Hanada, S; Hughes, WE; Ueda, K, 2022)
"Contrary to our hypothesis, in at-risk/type 2 diabetes patients, spironolactone did not reduce arterial stiffness, rather PWVart was lower on doxazosin."2.94A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone. ( Casagrande, ML; Crickmore, H; Cruickshank, JK; Faconti, L; Govoni, V; Iqbal, F; Masani, A; Maskell, P; Mills, CE; Morant, SV; Nanino, E; Webb, AJ, 2020)
"Twenty-four men with type 2 diabetes (72 ± 1 yr, 26."2.82Sodium nitrate co-ingestion with protein does not augment postprandial muscle protein synthesis rates in older, type 2 diabetes patients. ( Burd, NA; Cermak, NM; Churchward-Venne, TA; Gijsen, AP; Kouw, IW; Senden, JM; van Loon, LJ, 2016)
"Seventeen men with type 2 diabetes (glycated hemoglobin, 7."2.80A single dose of sodium nitrate does not improve oral glucose tolerance in patients with type 2 diabetes mellitus. ( Blackwell, JR; Cermak, NM; Gibala, MJ; Hansen, D; Jones, AM; Kouw, IW; van Dijk, JW; van Loon, LJ, 2015)
"Obesity, type 2 diabetes and the metabolic syndrome are associated with a decrease in NO bioavailability."2.53Dietary inorganic nitrate: From villain to hero in metabolic disease? ( Griffin, JL; McNally, B; Roberts, LD, 2016)
" Oxidative stress and reduced NO bioavailability are critically linked to development of hypertension and other forms of cardiovascular diseases."2.47Roles of dietary inorganic nitrate in cardiovascular health and disease. ( Carlström, M; Larsen, FJ; Lundberg, JO; Weitzberg, E, 2011)
"Sixty-six persons with type 2 diabetes were divided into HIIT, MICT, and control groups."1.72Improved blood pressure and flow-mediated dilatation via increased plasma adropin and nitrate/nitrite induced by high-intensity interval training in patients with type 2 diabetes. ( Ariabood, E; Asvadi-Fard, M; Bigi, MAB; Davoodi, M; Gaeini, AA; Ghardashi-Afousi, A; Hesamabadi, BK; Izadi, MR, 2022)
"Decreased nitric oxide (NO) bioavailability contributes to the pathophysiology of type 2 diabetes mellitus (T2DM)."1.62Effect of Nitrate on Gene and Protein Expression of Nitric Oxide Synthase Enzymes in Insulin-Sensitive Tissues of Type 2 Diabetic Male Rats ( Faridnouri, H; Ghasemi, A; Jeddi, S; Kashfi, K; Khorasani, V; Shokri, M, 2021)
"The best treatment for coronary artery disease (CAD) in patients with type 2 diabetes (DM2) and chronic kidney disease is unknown."1.62Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-up. ( Batista, DV; Filho, JPPL; Filho, RK; Garcia, RMR; Garzillo, CL; Hueb, W; Junior, CVS; Lima, EG; Martins, EB; Ramires, JAF; Rezende, PC, 2021)
"Anemia is common in patients with type 2 diabetes."1.51Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats. ( Ghasemi, A; Jeddi, S; Khorasani, V; Tohidi, M; Yaghmaei, P, 2019)
"Type 2 diabetes was induced by injection of streptozotocin and nicotinamide."1.43Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats. ( Bageripour, F; Ghanbari, M; Ghasemi, A; Jeddi, S; Khalifi, S, 2016)
" Nitrite significantly increased ischemic tissue NO bioavailability along with concomitant reduction of superoxide formation."1.40Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner. ( Bir, SC; Giordano, T; Kevil, CG; Kolluru, GK; Pardue, S; Pattillo, CB; Shen, X, 2014)
"Prior authorizations (PA) are intended to promote safe and cost-effective medication use."1.38Rosiglitazone prior authorization safety policy: a cohort study. ( Coleman, J; Fenrick, B; Gleason, PP; Starner, CI; Wickersham, P, 2012)
"Melatonin administration in NIDDM patients resulted in a significant increase in the morning melatonin concentration and SOD-1 activity, and a reduction in the MDA level and Cp oxidase activity."1.35Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients. ( Bartosz, G; Czuczejko, J; Kedziora, J; Kedziora-Kornatowska, K; Kornatowski, T; Kozakiewicz, M; Pawluk, H; Szewczyk-Golec, K, 2009)
"Diabetic nephropathy was exacerbated drastically by a nitric oxide synthase inhibitor and mildly by a NO precursor."1.33Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats. ( Higuchi, M; Hora, K; Kamijo, H, 2006)
"The 39 patients with type 2 diabetes included in this study were divided by stage of DR into 3 groups: group A, those without DR; group B, those with background/preproliferative DR; and group C, those with proliferative DR."1.32Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy. ( Biçer, N; Güner, G; Ozbay, D; Ozden, S; Tatlipinar, S; Yaylali, V; Yildirim, C, 2003)
"Both uncontrolled hypertension and type II diabetes mellitus, but not smoking, are associated with impaired vascular smooth-muscle reactivity induced by NO donors."1.32Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. ( Cittadino, M; Moreno, H; Sabha, M; Sousa, MG; Tácito, LH; Tanus-Santos, JE; Yugar-Toledo, JC, 2004)
" The differences appear to be due to defective nitric oxide production or bioavailability and might explain some of the propensity to develop end-stage renal disease."1.31Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin. ( Dalton, RN; Denver, E; Earle, KA; Mehrotra, S; Swaminathan, R, 2001)
" Chronic administration of L-NAME to rats induced reduced NO production and hypertension in both strains of rats."1.31Chronic feeding of a nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in type 2 diabetic model rats, Otsuka Long-Evans Tokushima Fatty rats, but not in nondiabetic rats. ( Ishimura, N; Nakaya, Y; Takahashi, A; Takishita, E, 2002)
"Moreover, in IDDM patients reduced nitrate/nitrite excretion was strongly associated with elevated plasmatic beta-thromboglobulin levels."1.30The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus. ( Huszka, M; Kaplar, M; Laszlo, P; Palatka, K; Rejto, L; Tornai, I; Udvardy, M, 1997)
" This study, taken with previous observations, suggests that factors other than diminished basal NO production, such as reduced bioavailability of NO probably due to the augmented production of superoxide anion with subsequently increased inactivation of NO, contribute to the high incidence of vascular disease in patients with noninsulin-dependent diabetes mellitus."1.30Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus. ( Andreoni, S; Carotta, M; Carzaniga, G; Catalano, M; Jun, T; Perilli, E; Scandale, G, 1997)
"Twenty-one consecutive patients (9 with type II diabetes mellitus, 12 non-diabetics) underwent coronary artery bypass grafting by one surgeon."1.30Elevated coronary endothelin-1 but not nitric oxide in diabetics during CABG. ( Alden, KJ; Ferguson, JL; Fogelson, BG; Law, WR; Nawas, SI; Sam, AD; Sharma, AC; Vigneswaran, WT, 1999)

Research

Studies (109)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (5.50)18.2507
2000's42 (38.53)29.6817
2010's45 (41.28)24.3611
2020's16 (14.68)2.80

Authors

AuthorsStudies
Bahadoran, Z1
Mirmiran, P1
Carlström, M4
Ghasemi, A9
Yousefzadeh, N3
Jeddi, S7
Shokri, M2
Afzali, H2
Norouzirad, R2
Kashfi, K3
Bock, JM2
Hughes, WE2
Ueda, K2
Feider, AJ2
Hanada, S2
Casey, DP2
Davoodi, M1
Hesamabadi, BK1
Ariabood, E1
Izadi, MR1
Ghardashi-Afousi, A1
Bigi, MAB1
Asvadi-Fard, M1
Gaeini, AA1
Shenouda, N1
Patik, JC1
Edwards, DG1
Turner, KD1
Kronemberger, A1
Bae, D1
de Sousa, LGO1
Harris, MP1
Anderson, EJ1
Bodine, SC1
Zimmerman, MB1
Lira, VA1
Qutob, HMH1
Saad, RA1
Bali, H1
Osailan, A1
Jaber, J1
Alzahrani, E1
Alyami, J1
Elsayed, H1
Alserihi, R1
Shaikhomar, OA1
Divya, KM1
Savitha, DP1
Krishna, GA1
Dhanya, TM1
Mohanan, PV1
Shah, SF1
Jafry, AT1
Hussain, G1
Kazim, AH1
Ali, M1
Rivani, E1
Endraswari, PD1
Widodo, ADW1
Khalil, MR1
Guldberg, R1
Nørgård, BM1
Uldbjerg, N1
Wehberg, S1
Fowobaje, KR1
Mashood, LO1
Ekholuenetale, M1
Ibidoja, OJ1
Romagnoli, A1
D'Agostino, M1
Pavoni, E1
Ardiccioni, C1
Motta, S1
Crippa, P1
Biagetti, G1
Notarstefano, V1
Rexha, J1
Perta, N1
Barocci, S1
Costabile, BK1
Colasurdo, G1
Caucci, S1
Mencarelli, D1
Turchetti, C1
Farina, M1
Pierantoni, L1
La Teana, A1
Al Hadi, R1
Cicconardi, F1
Chinappi, M1
Trucchi, E1
Mancia, F1
Menzo, S1
Morozzo Della Rocca, B1
D'Annessa, I1
Di Marino, D1
Choya, A1
de Rivas, B1
Gutiérrez-Ortiz, JI1
López-Fonseca, R1
Xu, S1
Cheng, B1
Huang, Z3
Liu, T3
Li, Y5
Jiang, L1
Guo, W2
Xiong, J1
Amirazodi, M1
Daryanoosh, F1
Mehrabi, A1
Gaeini, A1
Koushkie Jahromi, M1
Salesi, M1
Zarifkar, AH1
Studeny, P1
Netukova, M1
Nemcokova, M1
Klimesova, YM1
Krizova, D1
Kang, H1
Tao, Y1
Zhang, Q6
Sha, D1
Chen, Y1
Yao, J1
Gao, Y2
Liu, J5
Ji, L1
Shi, P1
Shi, C1
Wu, YL1
Wright, AI1
M El-Metwaly, N1
A Katouah, H1
El-Desouky, MG1
El-Bindary, AA1
El-Bindary, MA1
Kostakis, ID1
Raptis, DA1
Davidson, BR1
Iype, S1
Nasralla, D1
Imber, C1
Sharma, D1
Pissanou, T1
Pollok, JM1
Hughes, AM1
Sanderson, E1
Morris, T1
Ayorech, Z1
Tesli, M1
Ask, H1
Reichborn-Kjennerud, T1
Andreassen, OA1
Magnus, P1
Helgeland, Ø1
Johansson, S1
Njølstad, P1
Davey Smith, G1
Havdahl, A1
Howe, LD1
Davies, NM1
Amrillah, T1
Prasetio, A1
Supandi, AR1
Sidiq, DH1
Putra, FS1
Nugroho, MA1
Salsabilla, Z1
Azmi, R1
Grammatikopoulos, P1
Bouloumis, T1
Steinhauer, S1
Mironov, VS2
Bazhenova, TA2
Manakin, YV2
Yagubskii, EB2
Yakushev, IA1
Gilmutdinov, IF1
Simonov, SV1
Lan, K1
Yang, H1
Zheng, J2
Hu, H2
Zhu, T1
Zou, X1
Hu, B2
Liu, H5
Olokede, O1
Wu, H1
Holtzapple, M1
Gungor, O1
Kose, M1
Ghaemi, R1
Acker, M1
Stosic, A1
Jacobs, R1
Selvaganapathy, PR1
Ludwig, N1
Yerneni, SS1
Azambuja, JH1
Pietrowska, M1
Widłak, P1
Hinck, CS1
Głuszko, A1
Szczepański, MJ1
Kärmer, T1
Kallinger, I1
Schulz, D1
Bauer, RJ1
Spanier, G1
Spoerl, S1
Meier, JK1
Ettl, T1
Razzo, BM1
Reichert, TE1
Hinck, AP1
Whiteside, TL1
Wei, ZL1
Juan, W1
Tong, D1
Juan, LX1
Sa, LY1
Jie, HFM1
Xiao, G1
Xiang, LG1
Jie, HM1
Xu, C2
Yu, DN1
Yao, ZX1
Bigdeli, F1
Gao, XM1
Cheng, X1
Li, JZ1
Zhang, JW1
Wang, W5
Guan, ZJ1
Bu, Y1
Liu, KG1
Morsali, A1
Das, R1
Paul, R1
Parui, A1
Shrotri, A1
Atzori, C1
Lomachenko, KA1
Singh, AK1
Mondal, J1
Peter, SC1
Florimbio, AR1
Coughlin, LN1
Bauermeister, JA1
Young, SD1
Zimmerman, MA1
Walton, MA1
Bonar, EE1
Demir, D1
Balci, AB1
Kahraman, N1
Sunbul, SA1
Gucu, A1
Seker, IB1
Badem, S1
Yuksel, A1
Ozyazicioglu, AF1
Goncu, MT1
Zhang, H3
Zhou, H2
Deng, Z2
Luo, L2
Ong, SP1
Wang, C3
Xin, H1
Whittingham, MS1
Zhou, G1
Maemura, R1
Wakamatsu, M1
Matsumoto, K1
Sakaguchi, H1
Yoshida, N1
Hama, A1
Yoshida, T1
Miwata, S1
Kitazawa, H1
Narita, K1
Kataoka, S1
Ichikawa, D1
Hamada, M1
Taniguchi, R1
Suzuki, K1
Kawashima, N1
Nishikawa, E1
Narita, A1
Okuno, Y1
Nishio, N1
Kato, K1
Kojima, S1
Morita, K1
Muramatsu, H1
Takahashi, Y1
Yirgu, A1
Mekonnen, Y1
Eyado, A1
Staropoli, A1
Vinale, F1
Zac, J1
Zac, S1
Pérez-Padilla, R1
Remigio-Luna, A1
Guzmán-Boulloud, N1
Gochicoa-Rangel, L1
Guzmán-Valderrábano, C1
Thirión-Romero, I1
Statsenko, ME1
Turkina, SV1
Barantsevich, ER1
Karakulova, YV1
Baranova, NS1
Morzhukhina, MV1
Wang, Q3
Gu, Y1
Chen, C1
Qiao, L2
Pan, F1
Song, C1
Canetto, SS1
Entilli, L1
Cerbo, I1
Cipolletta, S1
Wu, Y4
Zhu, P1
Jiang, Y1
Zhang, X7
Wang, Z3
Xie, B1
Song, T1
Zhang, F1
Luo, A1
Li, S3
Xiong, X2
Han, J3
Peng, X2
Li, M1
Huang, L3
Chen, Q2
Fang, W1
Hou, Y1
Zhu, Y2
Ye, J2
Liu, L1
Islam, MR1
Sanderson, P1
Johansen, MP1
Payne, TE1
Naidu, R1
Cao, J1
Yang, J3
Niu, X1
Liu, X5
Zhai, Y1
Qiang, C1
Niu, Y1
Li, Z4
Dong, N1
Wen, B1
Ouyang, Z1
Zhang, Y9
Li, J9
Zhao, M2
Zhao, J1
Morici, P1
Rizzato, C1
Ghelardi, E1
Rossolini, GM1
Lupetti, A1
Gözüküçük, R1
Cakiroglu, B1
He, X1
Li, R1
Zhao, D2
Zhang, L5
Ji, X1
Fan, X1
Chen, J3
Wang, Y9
Luo, Y1
Zheng, D1
Xie, L1
Sun, S2
Cai, Z1
Liu, Q3
Ma, K1
Sun, X3
Drinkwater, JJ1
Davis, TME1
Turner, AW1
Davis, WA1
Suzuki, Y1
Mizuta, Y1
Mikagi, A1
Misawa-Suzuki, T1
Tsuchido, Y1
Sugaya, T1
Hashimoto, T1
Ema, K1
Hayashita, T1
Srour, B1
Chazelas, E1
Druesne-Pecollo, N1
Esseddik, Y1
de Edelenyi, FS1
Agaësse, C1
De Sa, A1
Lutchia, R1
Debras, C1
Sellem, L1
Huybrechts, I1
Julia, C1
Kesse-Guyot, E1
Allès, B1
Galan, P1
Hercberg, S1
Pierre, F1
Deschasaux-Tanguy, M1
Touvier, M1
Zarkesh, M1
Mills, CE4
Govoni, V3
Faconti, L4
Casagrande, ML2
Morant, SV2
Crickmore, H1
Iqbal, F1
Maskell, P1
Masani, A1
Nanino, E1
Webb, AJ4
Cruickshank, JK4
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L2
Zhao, Y3
Wang, J6
Hu, K1
Wang, H4
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X5
Yao, LP1
Qin, QP1
Wang, ZY1
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X6
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Xu, N1
Wang, R1
Liu, S2
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Zhang, C4
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H5
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Lu, Y1
Yan, R1
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Du, S1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L2
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y4
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Liu, M2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q2
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W2
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Shao, B1
Ma, X1
Bi, Z1
Liang, X2
Tie, Y1
Mo, F1
Xie, D2
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Huang, Y3
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Yu, J1
Tian, J1
Hu, J1
Yao, C1
Zhang, B2
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Kawazoe, Y1
Jena, P1
Sun, Z1
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F2
Lin, S1
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J3
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Azizi, S1
Ebrahimi-Mameghani, M1
Mobasseri, M1
Karamzad, N1
Mahdavi, R1
Adedayo, A1
Eluwole, A1
Tedla, F1
Kremer, A1
Mastrogiovanni, N1
Khan, M1
Rosenberg, C1
Dreizen, P1
La Rosa, J1
Salciccioli, L1
Boutjdir, M1
Banerji, MA1
Brown, C1
Salifu, M1
Lazar, J1
Bakillah, A1
Morselli, F1
Morant, S2
Chowienczyk, PJ1
Yeung, JA1
Cavarape, A1
Faridnouri, H1
Khorasani, V2
Batista, DV1
Hueb, W2
Lima, EG1
Rezende, PC1
Garzillo, CL1
Garcia, RMR1
Filho, JPPL1
Martins, EB1
Junior, CVS1
Ramires, JAF1
Filho, RK1
González-Muniesa, P1
Gheibi, S1
Gholami, H1
Jelić-Knezović, N1
Galijašević, S1
Lovrić, M1
Vasilj, M1
Selak, S1
Mikulić, I1
Mondal, LK1
Bhaduri, G1
Bhattacharya, B1
Lundberg, JO2
Weitzberg, E2
Drzayich Antol, D1
Waldman Casebeer, A1
Khoury, R1
Michael, T1
Renda, A1
Hopson, S1
Parikh, A1
Stein, A1
Costantino, M1
Stemkowski, S1
Bunce, M1
Nevo, N1
Abu-Abeid, S1
Hazzan, D1
Lahat, G1
Nachmani, I1
Eldar, SM1
Xia, X1
Zhong, Y1
Tu, J1
Gu, H1
Jiang, B1
Lin, J1
Wu, YJ1
Ji, M1
Ying, HM1
Wang, XY1
Shao, CH1
Zhan, LX1
Czamara, K1
Karnas, E1
Majka, Z1
Wojcik, T1
Zuba-Surma, EK1
Baranska, M1
Kaczor, A1
Zhou, F1
Niu, L1
Zuo, D1
Hua, H1
Kou, Y1
Guo, J1
Pan, W1
Gao, D1
Meves, JM1
Sun, H1
Xue, M1
Tang, R1
Iso, T1
Haruyama, H1
Sunaga, H1
Matsui, H1
Matsui, M1
Tanaka, R1
Umbarawan, Y1
Syamsunarno, MRAA1
Putri, M1
Yamaguchi, A1
Hanaoka, H1
Negishi, K1
Yokoyama, T1
Kurabayashi, M1
Palomo-Briones, R1
Esquivel-González, S1
Aizpuru, A1
Gómez-Hernández, N1
Casas-Flores, S1
Barba de la Rosa, AP1
Arriaga, S1
Peterson, ME1
Carothers, MA1
Gamble, DA1
Rishniw, M1
Yaghmaei, P1
Tohidi, M1
Tuzcu, H1
Aslan, I1
Aslan, M1
Salman, ZK1
Refaat, R1
Selima, E1
El Sarha, A1
Ismail, MA1
White, DL1
Collinson, A1
Bir, SC1
Pattillo, CB1
Pardue, S1
Kolluru, GK1
Shen, X1
Giordano, T1
Kevil, CG1
Savu, O1
Iosif, L1
Bradescu, OM1
Serafinceanu, C1
Papacocea, R1
Stoian, I1
Gilchrist, M4
Winyard, PG3
Fulford, J1
Anning, C2
Shore, AC2
Benjamin, N4
Sasongko, MB1
Wong, TY1
Jenkins, AJ1
Nguyen, TT1
Shaw, JE1
Wang, JJ1
Shepherd, AI1
Jones, AM2
Hallmann, E1
Kazimierczak, R1
Rembialkowska, E1
Wilkerson, DP1
Cermak, NM2
Hansen, D1
Kouw, IW2
van Dijk, JW1
Blackwell, JR1
Gibala, MJ1
van Loon, LJ2
McNally, B1
Griffin, JL1
Roberts, LD1
Rafraf, M1
Bazyun, B1
Sarabchian, MA1
Safaeiyan, A1
Gargari, BP1
Burd, NA1
Churchward-Venne, TA1
Senden, JM1
Gijsen, AP1
Chen, HJ1
Yang, YF1
Lai, PY1
Chen, PF1
Qiu, H1
Ho, KF1
Tian, L1
Khalifi, S1
Ghanbari, M1
Bageripour, F1
Ozcelik, O1
Algul, S1
Pereira, EC1
Ferderbar, S1
Bertolami, MC1
Faludi, AA1
Monte, O1
Xavier, HT1
Pereira, TV1
Abdalla, DS1
Nunes, SF2
Figueiredo, IV2
Soares, PJ1
Costa, NE1
Lopes, MC2
Caramona, MM2
Matsumoto, T5
Nakayama, N1
Ishida, K2
Kobayashi, T5
Kamata, K5
Kedziora-Kornatowska, K1
Szewczyk-Golec, K1
Kozakiewicz, M1
Pawluk, H1
Czuczejko, J1
Kornatowski, T1
Bartosz, G1
Kedziora, J1
Taguchi, K3
Inokuchi, C1
Ueda, H1
Hamaguchi, T1
Miyagawa, J1
Shinohara, M1
Okamura, H1
Namba, M1
Derosa, G1
D'Angelo, A1
Salvadeo, SA1
Ferrari, I1
Fogari, E1
Gravina, A1
Mereu, R1
Palumbo, I1
Maffioli, P1
Randazzo, S1
Cicero, AF1
Morgan, B1
Potter, BJ1
Dellsperger, KC1
Ungvari, Z1
Kudriashova, MV1
Dovgaliuk, IuV1
Mishina, LE1
Berezin, MV1
Grineva, MR1
Pakhrova, OA1
Mazanko, OE1
Erdmann, E1
Spanheimer, R1
Charbonnel, B1
Larsen, FJ1
Dagenais, GR1
Faxon, DP1
Kent, K1
Lago, RM1
Lezama, C1
Weiss, M1
Slater, J1
Frye, RL1
Mangialardi, G1
Monopoli, A1
Ongini, E1
Spinetti, G1
Fortunato, O1
Emanueli, C1
Madeddu, P1
King, DE1
Player, M1
Everett, CJ1
Siervo, M1
Jackson, SJ1
Bluck, LJ1
Pereira, JS1
Starner, CI1
Fenrick, B1
Coleman, J1
Wickersham, P1
Gleason, PP1
Morishige, A1
Imanishi, M1
Okada, N1
Konishi, Y1
Morikawa, T1
Maeda, I1
Kitabayashi, C1
Masada, M1
Shirahashi, N1
Wilcox, CS1
Nishiyama, A1
Lu, N1
Feng, Y1
Gao, Z1
Sharma, KK1
Guptha, S1
Gupta, R1
Stojanovic, I1
Djordjevic, G1
Pavlovic, R1
Djordjevic, V1
Pavlovic, D1
Cvetkovic, T1
Ljubisavljevic, S1
Basic, J1
Zabar, K1
Henning, SM1
Rahnama, N1
Zerlin, A1
Thames, G1
Tseng, CH1
Heber, D1
Aizawa, K1
Shore, A1
Pan, C1
Cassone Faldetta, M1
Laurenti, O1
Desideri, G1
Bravi, MC1
De Luca, O1
Marinucci, MC1
De Mattia, G1
Ferri, C1
Mirvish, SS1
Haorah, J1
Clapper, ML1
Harrison, KL1
Povey, AC1
Ohtoshi, K1
Yamasaki, Y1
Gorogawa, S1
Hayaishi-Okano, R1
Node, K1
Matsuhisa, M1
Kajimoto, Y1
Hori, M1
Avogaro, A2
Toffolo, G1
Kiwanuka, E1
de Kreutzenberg, SV1
Tessari, P1
Cobelli, C1
Bennett, KE1
Williams, D1
Feely, J1
Ozden, S1
Tatlipinar, S1
Biçer, N1
Yaylali, V1
Yildirim, C1
Ozbay, D1
Güner, G1
Bhatia, S1
Shukla, R1
Venkata Madhu, S1
Kaur Gambhir, J1
Madhava Prabhu, K1
Yugar-Toledo, JC1
Tanus-Santos, JE2
Sabha, M1
Sousa, MG1
Cittadino, M1
Tácito, LH1
Moreno, H1
Oomen, PH1
Kant, GD1
Dullaart, RP1
Tervaert, JW1
Reitsma, WD1
Smit, AJ1
Andreassi, MG1
Botto, N1
Simi, S1
Casella, M1
Manfredi, S1
Lucarelli, M1
Venneri, L1
Biagini, A1
Picano, E1
Hermo, R2
Mier, C1
Mazzotta, M1
Tsuji, M2
Kimura, S2
Gugliucci, A2
Fernández-Real, JM1
López-Bermejo, A1
Castro, A1
Broch, M1
Peñarroja, G1
Vendrell, J1
Vázquez, G1
Ricart, W1
Anderson, RA1
Ellis, GR1
Evans, LM1
Morris, K1
Chirkov, YY1
Horowitz, JD1
Jackson, SK1
Rees, A1
Lewis, MJ1
Frenneaux, MP1
Nourooz-Zadeh, J1
Jaffar, NZ1
Ziegler, D1
Dan, Z1
Sohr, C1
Christopher, S1
Betteridge, JD1
John, BD1
Knight, J1
Jan, K1
Hothersall, J1
John, H1
Szydłowska, E1
Szydłowski, W1
Zareba, S1
Kamijo, H1
Higuchi, M1
Hora, K1
Hayashi, T1
Juliet, PA1
Miyazaki-Akita, A1
Funami, J1
Matsui-Hirai, H1
Fukatsu, A1
Iguchi, A1
Sandrim, VC1
de Syllos, RW1
Lisboa, HR1
Tres, GS1
Yusuf, S1
Fallen, E1
Harrington, RA1
Guyton, RA1
Takenouchi, Y1
McVeigh, G1
Brennan, G1
Hayes, R1
Johnston, D1
Huszka, M1
Kaplar, M1
Rejto, L1
Tornai, I1
Palatka, K1
Laszlo, P1
Udvardy, M1
Catalano, M1
Carzaniga, G1
Perilli, E1
Jun, T1
Scandale, G1
Andreoni, S1
Carotta, M1
Tannous, M1
Rabini, RA1
Vignini, A1
Moretti, N1
Fumelli, P1
Zielinski, B1
Mazzanti, L1
Mutus, B1
Sharma, AC1
Fogelson, BG1
Nawas, SI1
Vigneswaran, WT1
Sam, AD1
Alden, KJ1
Ferguson, JL1
Law, WR1
Kurioka, S2
Koshimura, K2
Sugitani, M1
Murakami, Y2
Nishiki, M2
Kato, Y2
Daimon, M1
Sugiyama, K1
Saitoh, T1
Yamaguchi, H1
Hirata, A1
Ohnuma, H1
Igarashi, M1
Eguchi, H1
Manaka, H1
Kato, T1
Tonolo, G1
Melis, MG1
Formato, M1
Angius, MF1
Carboni, A1
Brizzi, P1
Ciccarese, M1
Cherchi, GM1
Maioli, M1
Kagota, S1
Yamaguchi, Y1
Nakamura, K1
Kunitomo, M1
Ferlito, S1
Gallina, M1
Aydin, A1
Orhan, H1
Sayal, A1
Ozata, M1
Sahin, G1
Işimer, A1
Francesconi, F1
Mingardi, R1
deKreutzenberg, S1
Hiragushi, K1
Sugimoto, H1
Shikata, K1
Yamashita, T1
Miyatake, N1
Shikata, Y1
Wada, J1
Kumagai, I1
Fukushima, M1
Makino, H1
Vanizor, B1
Orem, A1
Karahan, SC1
Kiran, E1
Erem, C1
Aliyazicioğlu, R1
Uydu, HA1
Earle, KA1
Mehrotra, S1
Dalton, RN1
Denver, E1
Swaminathan, R1
Maejima, K1
Himeno, M1
Ishibashi, T1
Nakano, S1
Nishio, M1
Uchida, K1
Deng, H1
Kanabrocki, EL1
Murray, D1
Hermida, RC1
Scott, GS1
Bremner, WF1
Ryan, MD1
Ayala, DE1
Third, JL1
Shirazi, P1
Nemchausky, BA1
Hooper, DC1
Nakaya, Y1
Ishimura, N1
Takishita, E1
Takahashi, A1

Clinical Trials (8)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes[NCT02804932]65 participants (Anticipated)Interventional2016-06-30Recruiting
The Effect of Dietary Nitrate Supplementation on Ability of Individuals With Type 2 Diabetes to Perform Exercise[NCT02206074]57 participants (Actual)Interventional2012-05-31Completed
PROspective PioglitAzone Clinical Trial In MacroVascular Events: A Macrovascular Outcome Study in Type 2 Diabetic Patients Comparing Pioglitazone With Placebo in Addition to Existing Therapy[NCT00174993]Phase 34,373 participants (Actual)Interventional2001-05-31Completed
Acute Effects of Beetroot Juice on Locomotor Economy and Capacity in Chronic Stroke[NCT05720013]25 participants (Anticipated)Interventional2023-02-01Recruiting
Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention[NCT03044964]Phase 440 participants (Anticipated)Interventional2017-01-10Recruiting
Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes[NCT00006305]Phase 32,368 participants (Actual)Interventional2000-09-30Completed
Effect of Oral Supplementation With One Form of L-arginine on Vascular Endothelial Function in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.[NCT02354794]36 participants (Actual)Interventional2014-02-28Completed
Characterization of the Metabolic Fate of an Oral L-arginine Form in Healthy Subjects Featuring Risk Factors Related to the Metabolic Syndrome.[NCT02352740]32 participants (Actual)Interventional2013-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With All-Cause Mortality

(NCT00006305)
Timeframe: five years

Interventionparticipants (Number)
Revascularization and Insulin Providing (IP)80
Revascularization and Insulin Sensitizing (IS)75
Medical Therapy and Insulin Providing (IP)80
Medical Therapy and Insulin Sensitizing (IS)81

Number of Participants With Death, Myocardial Infarction, or Stroke

(NCT00006305)
Timeframe: five years

Interventionparticipants (Number)
Revascularization and Insulin Providing (IP)145
Revascularization and Insulin Sensitizing (IS)121
Medical Therapy and Insulin Providing (IP)143
Medical Therapy and Insulin Sensitizing (IS)140

Reviews

9 reviews available for nitrates and Diabetes Mellitus, Adult-Onset

ArticleYear
Inorganic nitrate: A potential prebiotic for oral microbiota dysbiosis associated with type 2 diabetes.
    Nitric oxide : biology and chemistry, 2021, 11-01, Volume: 116

    Topics: Animals; Bacteria; Bacterial Proteins; Diabetes Mellitus, Type 2; Dysbiosis; Humans; Microbiota; Mou

2021
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Hypoxia in Obesity and Diabetes: Potential Therapeutic Effects of Hyperoxia and Nitrate.
    Oxidative medicine and cellular longevity, 2017, Volume: 2017

    Topics: Cell Hypoxia; Diabetes Mellitus, Type 2; Hyperoxia; Inflammation; Nitrates; Obesity; Oxidative Stres

2017
Metabolic Effects of Dietary Nitrate in Health and Disease.
    Cell metabolism, 2018, Jul-03, Volume: 28, Issue:1

    Topics: Animals; Cardiovascular System; Diabetes Mellitus, Type 2; Diet; Humans; Metabolic Syndrome; Mice; M

2018
Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts.
    Advances in nutrition (Bethesda, Md.), 2013, Jul-01, Volume: 4, Issue:4

    Topics: Animals; Cohort Studies; Diabetes Mellitus, Type 2; Diet; Female; Ferritins; Food Handling; Glycatio

2013
Dietary inorganic nitrate: From villain to hero in metabolic disease?
    Molecular nutrition & food research, 2016, Volume: 60, Issue:1

    Topics: Adipose Tissue; Biological Availability; Diabetes Mellitus, Type 2; Diet; Heart; Humans; Hypertensio

2016
Roles of dietary inorganic nitrate in cardiovascular health and disease.
    Cardiovascular research, 2011, Feb-15, Volume: 89, Issue:3

    Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Humans; Nitrates

2011
Total N-nitroso compounds and their precursors in hot dogs and in the gastrointestinal tract and feces of rats and mice: possible etiologic agents for colon cancer.
    The Journal of nutrition, 2002, Volume: 132, Issue:11 Suppl

    Topics: Animals; Cattle; Child; Colitis; Colonic Neoplasms; Deoxyguanosine; Diabetes Mellitus, Type 2; Diges

2002

Trials

25 trials available for nitrates and Diabetes Mellitus, Adult-Onset

ArticleYear
Dietary Inorganic Nitrate/Nitrite Supplementation Reduces Central and Peripheral Blood Pressure in Patients With Type 2 Diabetes Mellitus.
    American journal of hypertension, 2022, 09-01, Volume: 35, Issue:9

    Topics: Beta vulgaris; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method;

2022
Effects of Combined Inorganic Nitrate and Nitrite Supplementation on Cardiorespiratory Fitness and Skeletal Muscle Oxidative Capacity in Type 2 Diabetes: A Pilot Randomized Controlled Trial.
    Nutrients, 2022, Oct-25, Volume: 14, Issue:21

    Topics: Aged; Beta vulgaris; Carbohydrates; Cardiorespiratory Fitness; Diabetes Mellitus, Type 2; Dietary Su

2022
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
    Medicina clinica (English ed.), 2022, Dec-23, Volume: 159, Issue:12

    Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter

2022
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.
    British journal of clinical pharmacology, 2020, Volume: 86, Issue:5

    Topics: Adult; Aged; Beta vulgaris; Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Double-B

2020
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Oxidative stress and nitrate/nitrite (NOx) status following citrulline supplementation in type 2 diabetes: a randomised, double-blind, placebo-controlled trial.
    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2021, Volume: 34, Issue:1

    Topics: Adult; Antioxidants; Blood Glucose; Citrulline; Diabetes Mellitus, Type 2; Dietary Supplements; Doub

2021
Dietary nitrate prevents progression of carotid subclinical atherosclerosis through blood pressure-independent mechanisms in patients with or at risk of type 2 diabetes mellitus.
    British journal of clinical pharmacology, 2021, Volume: 87, Issue:12

    Topics: Atherosclerosis; Beta vulgaris; Blood Pressure; Carotid Intima-Media Thickness; Diabetes Mellitus, T

2021
Reducing Arterial Stiffness Independently of Blood Pressure: The VaSera Trial.
    Journal of the American College of Cardiology, 2017, 09-26, Volume: 70, Issue:13

    Topics: Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Double-Blind Method; Doxazosin;

2017
    Journal of patient-reported outcomes, 2018, Volume: 2

    Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Bloo

2018
Dietary nitrate supplementation improves reaction time in type 2 diabetes: development and application of a novel nitrate-depleted beetroot juice placebo.
    Nitric oxide : biology and chemistry, 2014, Aug-31, Volume: 40

    Topics: Aged; Beta vulgaris; Beverages; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements;

2014
Effects of dietary nitrate supplementation on the oxygen cost of exercise and walking performance in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled crossover trial.
    Free radical biology & medicine, 2015, Volume: 86

    Topics: Aged; Antioxidants; Beta vulgaris; Combined Modality Therapy; Cross-Over Studies; Diabetes Mellitus,

2015
A single dose of sodium nitrate does not improve oral glucose tolerance in patients with type 2 diabetes mellitus.
    Nutrition research (New York, N.Y.), 2015, Volume: 35, Issue:8

    Topics: Aged; Beverages; Blood Glucose; Blood Pressure; Body Mass Index; Cross-Over Studies; Diabetes Mellit

2015
Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels.
    Journal of the American College of Nutrition, 2016, Volume: 35, Issue:6

    Topics: Adult; Antioxidants; Aryldialkylphosphatase; Blood Glucose; Diabetes Complications; Diabetes Mellitu

2016
Sodium nitrate co-ingestion with protein does not augment postprandial muscle protein synthesis rates in older, type 2 diabetes patients.
    American journal of physiology. Endocrinology and metabolism, 2016, 08-01, Volume: 311, Issue:2

    Topics: Aged; Blood Glucose; Carbon Isotopes; Diabetes Mellitus, Type 2; Dietary Proteins; Eating; Glycated

2016
Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20).
    Journal of diabetes, 2010, Volume: 2, Issue:3

    Topics: Age of Onset; Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic An

2010
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Circulation, 2011, Apr-12, Volume: 123, Issue:14

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel

2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Circulation, 2011, Apr-12, Volume: 123, Issue:14

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel

2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Circulation, 2011, Apr-12, Volume: 123, Issue:14

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel

2011
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease.
    Circulation, 2011, Apr-12, Volume: 123, Issue:14

    Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel

2011
The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes.
    Primary care diabetes, 2012, Volume: 6, Issue:2

    Topics: Academic Medical Centers; Arginine; Biomarkers; Cross-Over Studies; Diabetes Mellitus, Type 2; Dinop

2012
Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2013, Volume: 14, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Albuminuria; Angiotensin Receptor Antagonists; Biopterins; Blood Pressu

2013
Decrease of postprandial endothelial dysfunction by spice mix added to high-fat hamburger meat in men with Type 2 diabetes mellitus.
    Diabetic medicine : a journal of the British Diabetic Association, 2013, Volume: 30, Issue:5

    Topics: Animals; Blood Glucose; Cattle; Cooking; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelium, Vas

2013
Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes.
    Free radical biology & medicine, 2013, Volume: 60

    Topics: Aged; Beta vulgaris; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dietary Sup

2013
L-arginine infusion decreases plasma total homocysteine concentrations through increased nitric oxide production and decreased oxidative status in Type II diabetic patients.
    Diabetologia, 2002, Volume: 45, Issue:8

    Topics: Arginine; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female

2002
No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus.
    Scandinavian journal of clinical and laboratory investigation, 2004, Volume: 64, Issue:2

    Topics: Antigens; Biomarkers; Capillary Permeability; Diabetes Mellitus, Type 2; Endothelial Cells; Fluoresc

2004
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.
    European journal of clinical investigation, 2000, Volume: 30, Issue:11

    Topics: Albuminuria; Anticholesteremic Agents; Apolipoproteins; Blood Pressure; Cholesterol, LDL; Cholestyra

2000
Effect of metabolic control on nitrite and nitrate metabolism in type 2 diabetic patients.
    Clinical and experimental pharmacology & physiology, 2001, Volume: 28, Issue:7

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Diet; Energy Intake; Female; Humans; Male; Middle Aged; Ni

2001
Paradoxical decrease in plasma NOx by L-arginine load in diabetic and non-diabetic subjects.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2002, Volume: 24, Issue:3

    Topics: Arginine; Blood Glucose; Blood Pressure; Cyclic GMP; Diabetes Mellitus, Type 2; Endothelium, Vascula

2002

Other Studies

77 other studies available for nitrates and Diabetes Mellitus, Adult-Onset

ArticleYear
Long Term Sodium Nitrate Administration Positively Impacts Metabolic and Obesity Indices in Ovariectomized Rats.
    Archives of medical research, 2022, Volume: 53, Issue:2

    Topics: Adiposity; Animals; Diabetes Mellitus, Type 2; Female; Nitrates; Obesity; Rats

2022
Improved blood pressure and flow-mediated dilatation via increased plasma adropin and nitrate/nitrite induced by high-intensity interval training in patients with type 2 diabetes.
    Experimental physiology, 2022, Volume: 107, Issue:8

    Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Dilatation; High-Intensity Interval Training; Human

2022
Reflecting on the Blood Pressure Lowering Effects of Inorganic Nitrate Supplementation in Patients With Type 2 Diabetes.
    American journal of hypertension, 2022, 09-01, Volume: 35, Issue:9

    Topics: Blood Pressure; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Nitrates; Nitrites

2022
Dietary exposure to nitrites and nitrates in association with type 2 diabetes risk: Results from the NutriNet-Santé population-based cohort study.
    PLoS medicine, 2023, Volume: 20, Issue:1

    Topics: Adult; Cohort Studies; Diabetes Mellitus, Type 2; Diet; Dietary Exposure; Drinking Water; Female; Fo

2023
Altered sialin mRNA gene expression in type 2 diabetic male Wistar rats: implications for nitric oxide deficiency.
    Scientific reports, 2023, 03-10, Volume: 13, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression; Male; Nitrates

2023
Long-term nitrate administration increases expression of browning genes in epididymal adipose tissue of male type 2 diabetic rats.
    Gene, 2021, Jan-15, Volume: 766

    Topics: Adipocytes; Adipocytes, Brown; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Blood Glucose;

2021
Association between nitrated lipoproteins and vascular function in type 2 diabetes.
    Frontiers in bioscience (Landmark edition), 2021, 01-01, Volume: 26, Issue:4

    Topics: Aged; Biomarkers; Blood Vessels; Case-Control Studies; Cholesterol, HDL; Diabetes Mellitus, Type 2;

2021
Effect of Nitrate on Gene and Protein Expression of Nitric Oxide Synthase Enzymes in Insulin-Sensitive Tissues of Type 2 Diabetic Male Rats
    Endocrine, metabolic & immune disorders drug targets, 2021, Volume: 21, Issue:12

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Male; Nitrates; Nitric

2021
Effect of diabetic kidney disease on therapeutic strategies for coronary artery disease: ten year follow-up.
    Aging, 2021, 08-25, Volume: 13, Issue:16

    Topics: Aged; Aspirin; Calcium Channel Blockers; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabeti

2021
Effects of long-term nitrate supplementation on carbohydrate metabolism, lipid profiles, oxidative stress, and inflammation in male obese type 2 diabetic rats.
    Nitric oxide : biology and chemistry, 2018, 05-01, Volume: 75

    Topics: Animals; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet,

2018
Levels of Nitric Oxide Metabolites and Myeloperoxidase in Subjects with Type 2 Diabetes Mellitus on Metformin Therapy .
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2019, Volume: 127, Issue:1

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glycated Hemoglobin; Humans;

2019
Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus.
    Indian journal of ophthalmology, 2018, Volume: 66, Issue:4

    Topics: Adult; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retin

2018
Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats.
    Nitric oxide : biology and chemistry, 2019, 05-01, Volume: 86

    Topics: Administration, Oral; Anemia; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mell

2019
The effect of high-dose insulin analog initiation therapy on lipid peroxidation products and oxidative stress markers in type 2 diabetic patients.
    Oxidative medicine and cellular longevity, 2013, Volume: 2013

    Topics: Adult; Aged; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dinoprost; Drug Therapy, Combinat

2013
The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
    European journal of pharmacology, 2013, Aug-15, Volume: 714, Issue:1-3

    Topics: Animals; Body Weight; C-Reactive Protein; Caspase 3; Chemokine CCL2; Cysteine; Cytochromes c; Diabet

2013
Nitrite anion therapy protects against chronic ischemic tissue injury in db/db diabetic mice in a NO/VEGF-dependent manner.
    Diabetes, 2014, Volume: 63, Issue:1

    Topics: Animals; Diabetes Mellitus, Type 2; Femoral Artery; Hindlimb; Ischemia; Mice; Neovascularization, Pa

2014
L-arginine catabolism is driven mainly towards nitric oxide synthesis in the erythrocytes of patients with type 2 diabetes at first clinical onset.
    Annals of clinical biochemistry, 2015, Volume: 52, Issue:Pt 1

    Topics: Arginase; Arginine; Case-Control Studies; Diabetes Mellitus, Type 2; Electrophoresis, Capillary; Ery

2015
Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy.
    Diabetic medicine : a journal of the British Diabetic Association, 2015, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Diabetes Mellitus,

2015
Analysis of Chlorination, Nitration, and Nitrosylation of Tyrosine and Oxidation of Methionine and Cysteine in Hemoglobin from Type 2 Diabetes Mellitus Patients by Nanoflow Liquid Chromatography Tandem Mass Spectrometry.
    Analytical chemistry, 2016, 09-20, Volume: 88, Issue:18

    Topics: Adult; Aged; Amino Acid Sequence; Cysteine; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin;

2016
Chemical components of respirable particulate matter associated with emergency hospital admissions for type 2 diabetes mellitus in Hong Kong.
    Environment international, 2016, Volume: 97

    Topics: Aged; Aged, 80 and over; Air Pollutants; Carbon; Diabetes Mellitus, Type 2; Disease Progression; Eme

2016
Effects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.
    Arquivos brasileiros de cardiologia, 2016, Volume: 107, Issue:4

    Topics: Animals; Cardiotonic Agents; Coronary Vessels; Diabetes Mellitus, Experimental; Diabetes Mellitus, T

2016
Nitric oxide levels in response to the patients with different stage of diabetes.
    Cellular and molecular biology (Noisy-le-Grand, France), 2017, Feb-22, Volume: 63, Issue:1

    Topics: Adult; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Insulin

2017
Biomarkers of oxidative stress and endothelial dysfunction in glucose intolerance and diabetes mellitus.
    Clinical biochemistry, 2008, Volume: 41, Issue:18

    Topics: Arginine; Biomarkers; Body Mass Index; Diabetes Mellitus, Type 2; Endothelium; Female; Glucose Intol

2008
Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes?
    Acta diabetologica, 2009, Volume: 46, Issue:2

    Topics: Administration, Oral; Aged; Aged, 80 and over; Albuminuria; Amine Oxidase (Copper-Containing); Bioma

2009
Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 329, Issue:1

    Topics: Animals; Blood Chemical Analysis; Blood Pressure; Blotting, Western; Chronic Disease; Diabetes Melli

2009
Melatonin improves oxidative stress parameters measured in the blood of elderly type 2 diabetic patients.
    Journal of pineal research, 2009, Volume: 46, Issue:3

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Antioxidants; Diabetes Mellitus, Type 2; Dietary Supp

2009
Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
    Peptides, 2009, Volume: 30, Issue:9

    Topics: Acetylcholine; Animals; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 2; Dose-Response Relation

2009
Role of macrophages in the development of pancreatic islet injury in spontaneously diabetic torii rats.
    Experimental animals, 2009, Volume: 58, Issue:4

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone Density Conservation Agents;

2009
Modification of vascular and inflammation biomarkers after OGTT in overweight healthy and diabetic subjects.
    Microvascular research, 2010, Volume: 79, Issue:2

    Topics: Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glucose Tolerance Test; Humans; Male;

2010
Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.
    American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:4

    Topics: Animals; Antioxidants; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Magnetic Resonance

2010
[Possibilities of correction of rheological properties of the blood and free radical processess in patients with acute myocardial infarction combined with type 2 diabetes mellitus].
    Kardiologiia, 2010, Volume: 50, Issue:5

    Topics: Arrhythmias, Cardiac; Blood Viscosity; Diabetes Mellitus, Type 2; Electrocardiography; Electrocardio

2010
Vegetables and diabetes. Is nitrate the answer?
    BMJ (Clinical research ed.), 2010, Sep-28, Volume: 341

    Topics: Diabetes Mellitus, Type 2; Fruit; Humans; Nitrates; Vegetables

2010
Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.
    British journal of pharmacology, 2011, Volume: 164, Issue:2b

    Topics: Aged; Anticholesteremic Agents; Apoptosis; Benzoates; Cardiovascular Agents; Cardiovascular Diseases

2011
In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method.
    Journal of hypertension, 2011, Volume: 29, Issue:8

    Topics: Adult; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Diagnostic Tests, Routine; Fema

2011
In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method.
    Journal of hypertension, 2011, Volume: 29, Issue:8

    Topics: Adult; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Diagnostic Tests, Routine; Fema

2011
In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method.
    Journal of hypertension, 2011, Volume: 29, Issue:8

    Topics: Adult; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Diagnostic Tests, Routine; Fema

2011
In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method.
    Journal of hypertension, 2011, Volume: 29, Issue:8

    Topics: Adult; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Diagnostic Tests, Routine; Fema

2011
Correlation between total nitrite/nitrate concentrations and monoamine oxidase (types A and B) and semicarbazide-sensitive amine oxidase enzymatic activities in human mesenteric arteries from non-diabetic and type 2 diabetic patients.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2012, Volume: 45, Issue:1

    Topics: Aged; Amine Oxidase (Copper-Containing); Case-Control Studies; Diabetes Mellitus, Type 2; Female; Hu

2012
Rosiglitazone prior authorization safety policy: a cohort study.
    Journal of managed care pharmacy : JMCP, 2012, Volume: 18, Issue:3

    Topics: Blue Cross Blue Shield Insurance Plans; Cohort Studies; Contraindications; Diabetes Mellitus, Type 2

2012
Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction.
    Endocrinology, 2012, Volume: 153, Issue:7

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Blood Pre

2012
Enhanced estradiol-induced vasorelaxation in aortas from type 2 diabetic mice may reflect a compensatory role of p38 MAPK-mediated eNOS activation.
    Pflugers Archiv : European journal of physiology, 2012, Volume: 464, Issue:2

    Topics: Animals; Aorta; Diabetes Mellitus, Type 2; Disease Models, Animal; Estradiol; Estrogens; Female; In

2012
Iron increases liver injury through oxidative/nitrative stress in diabetic rats: Involvement of nitrotyrosination of glucokinase.
    Biochimie, 2012, Volume: 94, Issue:12

    Topics: Animals; Blotting, Western; Body Weight; Diabetes Mellitus, Type 2; Glucokinase; Iron; Iron Overload

2012
Secondary prevention therapies for coronary heart disease in patients with type 2 diabetes: an audit.
    The Journal of the Association of Physicians of India, 2012, Volume: 60

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme I

2012
The importance of L-arginine metabolism modulation in diabetic patients with distal symmetric polyneuropathy.
    Journal of the neurological sciences, 2013, Jan-15, Volume: 324, Issue:1-2

    Topics: Aged; Arginase; Arginine; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Ty

2013
[The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy].
    Zhonghua yi xue za zhi, 2002, Jun-10, Volume: 82, Issue:11

    Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fasting; Female; Homocysteine; Humans; Hyperh

2002
Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance.
    Diabetologia, 2002, Volume: 45, Issue:11

    Topics: Adult; Aged; Asian People; Base Sequence; Blood Pressure; Cytidine; Diabetes Mellitus, Type 2; DNA P

2002
L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: Arginine; Diabetes Mellitus, Type 2; Humans; Kinetics; Male; Nitrates; Nitric Oxide; Nitrogen Isotop

2003
Under-prescribing of cardiovascular therapies for diabetes in primary care.
    European journal of clinical pharmacology, 2003, Volume: 58, Issue:12

    Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit

2003
Basal serum nitric oxide levels in patients with type 2 diabetes mellitus and different stages of retinopathy.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2003, Volume: 38, Issue:5

    Topics: Adult; Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans;

2003
Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy.
    Clinical biochemistry, 2003, Volume: 36, Issue:7

    Topics: Antioxidants; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Erythrocytes; Female; Glutathione;

2003
Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction.
    Chest, 2004, Volume: 125, Issue:3

    Topics: Adult; Blood Flow Velocity; Cyclic GMP; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Hy

2004
Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease.
    Journal of molecular medicine (Berlin, Germany), 2005, Volume: 83, Issue:4

    Topics: Coronary Angiography; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus, Type 2; DN

2005
Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients.
    Clinical chemistry and laboratory medicine, 2005, Volume: 43, Issue:6

    Topics: Aged; Apolipoprotein A-I; Arteriosclerosis; Biomarkers; Case-Control Studies; Diabetes Complications

2005
Opposite relationship between circulating soluble CD14 concentration and endothelial function in diabetic and nondiabetic subjects.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:3

    Topics: Brachial Artery; C-Reactive Protein; Cross-Sectional Studies; Cyclic GMP; Diabetes Mellitus, Type 2;

2005
Platelet nitrate responsiveness in fasting and postprandial type 2 diabetes.
    Diabetes & vascular disease research, 2005, Volume: 2, Issue:2

    Topics: Adenosine Diphosphate; Adult; Aged; Blood Platelets; Brachial Artery; Diabetes Mellitus, Type 2; Fas

2005
The use of pholasin as a probe for the determination of plasma total antioxidant capacity.
    Clinical biochemistry, 2006, Volume: 39, Issue:1

    Topics: Adult; Antioxidants; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Firefly Luciferin; Humans

2006
Lower serum paraoxonase-1 activity in type 2 diabetic patients correlates with nitrated apolipoprotein A-I levels.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 368, Issue:1-2

    Topics: Apolipoprotein A-I; Aryldialkylphosphatase; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle

2006
[Nitrite and nitrate content in selected herbal medicaments used in obesity and diabetes mellitus type 2 treatment].
    Przeglad lekarski, 2005, Volume: 62, Issue:8

    Topics: Diabetes Mellitus, Type 2; Humans; Nitrates; Nitrites; Obesity; Plants, Medicinal; Spectrophotometry

2005
Chronic inhibition of nitric oxide production aggravates diabetic nephropathy in Otsuka Long-Evans Tokushima Fatty rats.
    Nephron. Physiology, 2006, Volume: 104, Issue:1

    Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Kidney Glom

2006
beta1 antagonist and beta2 agonist, celiprolol, restores the impaired endothelial dependent and independent responses and decreased TNFalpha in rat with type II diabetes.
    Life sciences, 2007, Jan-16, Volume: 80, Issue:6

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Aorta, Abdomin

2007
Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients.
    Nitric oxide : biology and chemistry, 2007, Volume: 16, Issue:3

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Gene Frequency; Genotype; Haplotypes; Humans; Hypert

2007
Clinical decisions. Management of stable coronary disease.
    The New England journal of medicine, 2007, Oct-25, Volume: 357, Issue:17

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Coronary Disease; Diabetes Me

2007
Possible involvement of Akt activity in endothelial dysfunction in type 2 diabetic mice.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:4

    Topics: Adrenomedullin; Animals; Aorta; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Clonidine;

2008
Primary nitrate tolerance in diabetes mellitus.
    Diabetologia, 1994, Volume: 37, Issue:1

    Topics: Acetylcholine; Arterioles; Diabetes Mellitus, Type 2; Drug Tolerance; Endothelium, Vascular; Forearm

1994
The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus.
    Thrombosis research, 1997, Apr-15, Volume: 86, Issue:2

    Topics: Adult; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes

1997
Basal nitric oxide production is not reduced in patients with noninsulin-dependent diabetes mellitus.
    Vascular medicine (London, England), 1997, Volume: 2, Issue:4

    Topics: Aged; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Humans; Male;

1997
Evidence for iNOS-dependent peroxynitrite production in diabetic platelets.
    Diabetologia, 1999, Volume: 42, Issue:5

    Topics: Adult; Arginine; Blood Platelets; Blotting, Western; Diabetes Mellitus, Type 1; Diabetes Mellitus, T

1999
Elevated coronary endothelin-1 but not nitric oxide in diabetics during CABG.
    The Annals of thoracic surgery, 1999, Volume: 67, Issue:6

    Topics: Coronary Artery Bypass; Diabetes Mellitus, Type 2; Endothelin-1; Female; Heart Arrest, Induced; Hemo

1999
Analysis of urinary nitric oxide metabolites in healthy subjects.
    Endocrine journal, 1999, Volume: 46, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Arthritis, Rheumatoid; Chromatography, High Press

1999
Reverse correlation between urine nitric oxide metabolites and insulin resistance in patients with type 2 diabetes mellitus.
    Endocrine journal, 2000, Volume: 47, Issue:1

    Topics: Adult; Aged; Body Mass Index; Diabetes Mellitus, Type 2; Female; Glucose; Glucose Clamp Technique; H

2000
Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes.
    Diabetes care, 2000, Volume: 23, Issue:4

    Topics: Ceruloplasmin; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Ni

2000
Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus.
    General pharmacology, 2000, Volume: 34, Issue:3

    Topics: Acetylcholine; Animals; Aorta; Biological Factors; Blood Glucose; Body Weight; Cardiovascular Agents

2000
Nitrite, endothelin and E-selectin plasma levels after arginine infusion in normal, obese and type 2 diabetic subjects.
    Minerva endocrinologica, 2000, Volume: 25, Issue:2

    Topics: Analysis of Variance; Arginine; Case-Control Studies; Diabetes Mellitus, Type 2; E-Selectin; Endothe

2000
Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control.
    Clinical biochemistry, 2001, Volume: 34, Issue:1

    Topics: Adult; Aged; Case-Control Studies; Catalase; Cyclic GMP; Diabetes Mellitus, Type 2; Erythrocytes; Fe

2001
Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes.
    Diabetes research and clinical practice, 2001, Volume: 53, Issue:3

    Topics: Adult; Age Factors; Aged; Albuminuria; Animals; Blood Glucose; Blood Pressure; Creatinine; Cross-Sec

2001
Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications.
    Diabetes research and clinical practice, 2001, Volume: 54, Issue:1

    Topics: Apolipoproteins; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Di

2001
Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin.
    Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:10

    Topics: Africa; Aged; Albuminuria; Asian People; Black People; Diabetes Mellitus, Type 2; Ethnicity; Female;

2001
[The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus].
    Zhonghua nei ke za zhi, 2002, Volume: 41, Issue:3

    Topics: Adult; Aryldialkylphosphatase; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Esterases; Female;

2002
Circadian variation in oxidative stress markers in healthy and type II diabetic men.
    Chronobiology international, 2002, Volume: 19, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Case-Control Studies; Circadian Rhythm; Deoxyg

2002
Chronic feeding of a nitric oxide synthase inhibitor induces postprandial hypertriglyceridemia in type 2 diabetic model rats, Otsuka Long-Evans Tokushima Fatty rats, but not in nondiabetic rats.
    Metabolism: clinical and experimental, 2002, Volume: 51, Issue:6

    Topics: Animals; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus; Diabetes Mellitus,

2002